BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 30815953)

  • 1. Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.
    Puccini A; Nardin S; Trevisan L; Lastraioli S; Gismondi V; Ricciotti I; Damiani A; Bregni G; Murialdo R; Pastorino A; Martelli V; Gandini A; Mastracci L; Varesco L; Dono M; Battistuzzi L; Grillo F; Sciallero S
    Eur J Cancer Prev; 2024 Jul; 33(4):355-362. PubMed ID: 38190337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
    BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway.
    McRonald FE; Pethick J; Santaniello F; Shand B; Tyson A; Tulloch O; Goel S; Lüchtenborg M; Borthwick GM; Turnbull C; Shaw AC; Monahan KJ; Frayling IM; Hardy S; Burn J
    Eur J Hum Genet; 2024 May; 32(5):529-538. PubMed ID: 38355963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: The RM Partners quality improvement project.
    Monje-Garcia L; Bill T; Farthing L; Hill N; Kipps E; Brady AF; Kemp Z; Snape K; Myers A; Abulafi M; Monahan K
    Colorectal Dis; 2023 Sep; 25(9):1844-1851. PubMed ID: 37553835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
    Pearlman R; Frankel WL; Swanson BJ; Jones D; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Prior TW; Haut M; Kalady MF; Heald B; Paquette I; Draper DJ; Brell JM; Mahesh S; Weeman K; Bastola S; Zangmeister J; Gowda A; Kencana F; Malcolm A; Liu Y; Cole S; Bane C; Li C; Rehmus E; Pritchard CC; Shirts BH; Jacobson A; Cummings SA; de la Chapelle A; Hampel H
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
    Cragun D; DeBate RD; Vadaparampil ST; Baldwin J; Hampel H; Pal T
    Genet Med; 2014 Oct; 16(10):773-82. PubMed ID: 24651603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of neutrophil-rich colorectal carcinoma.
    Rottmann BG; Patel N; Ahmed M; Deng Y; Ciarleglio M; Vyas M; Jain D; Zhang X
    J Clin Pathol; 2023 Jan; 76(1):34-39. PubMed ID: 34312298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals.
    Steinberg J; Chan P; Hogden E; Tiernan G; Morrow A; Kang YJ; He E; Venchiarutti R; Titterton L; Sankey L; Pearn A; Nichols C; McKay S; Hayward A; Egoroff N; Engel A; Gibbs P; Goodwin A; Harris M; Kench JG; Pachter N; Parkinson B; Pockney P; Ragunathan A; Smyth C; Solomon M; Steffens D; Toh JWT; Wallace M; Canfell K; Gill A; Macrae F; Tucker K; Taylor N
    Hered Cancer Clin Pract; 2022 May; 20(1):18. PubMed ID: 35509103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Go ahead and screen" - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients.
    Schneider JL; Firemark AJ; Gille S; Davis J; Pawloski PA; Liang SY; Epstein MM; Lowery J; Lu CY; Sharaf RN; Burnett-Hartman AN; Schlieder V; Salvati ZM; Cragun D; Rahm AK; Hunter JE
    Hered Cancer Clin Pract; 2023 Nov; 21(1):24. PubMed ID: 37978552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient.
    Iqbal A; Rabat SK; Kaur R; Waqas M; Badar S; Haider F; Syed M; Thomas L
    Cureus; 2023 Nov; 15(11):e48740. PubMed ID: 38094538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.
    Schneider JL; Davis J; Kauffman TL; Reiss JA; McGinley C; Arnold K; Zepp J; Gilmore M; Muessig KR; Syngal S; Acheson L; Wiesner GL; Peterson SK; Goddard KA
    Genet Med; 2016 Feb; 18(2):152-61. PubMed ID: 25880440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary cancer syndromes.
    Imyanitov EN; Kuligina ES; Sokolenko AP; Suspitsin EN; Yanus GA; Iyevleva AG; Ivantsov AO; Aleksakhina SN
    World J Clin Oncol; 2023 Feb; 14(2):40-68. PubMed ID: 36908677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis.
    Aiyer KTS; Doeleman T; Ryan NA; Nielsen M; Crosbie EJ; Smit VTHBM; Morreau H; Goeman JJ; Bosse T
    Mod Pathol; 2022 Dec; 35(12):1775-1783. PubMed ID: 36104536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.
    Salikhanov I; Heinimann K; Chappuis P; Buerki N; Graffeo R; Heinzelmann V; Rabaglio M; Taborelli M; Wieser S; Katapodi MC
    J Med Genet; 2022 Sep; 59(9):924-930. PubMed ID: 34782441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).
    Monahan KJ; Bradshaw N; Dolwani S; Desouza B; Dunlop MG; East JE; Ilyas M; Kaur A; Lalloo F; Latchford A; Rutter MD; Tomlinson I; Thomas HJW; Hill J;
    Gut; 2020 Mar; 69(3):411-444. PubMed ID: 31780574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Identification of Lynch Syndrome in Gastroenterology Practice.
    Muller C; Matthews L; Kupfer SS; Weiss JM
    Curr Treat Options Gastroenterol; 2019 Dec; 17(4):666-680. PubMed ID: 31677041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom.
    Cavazza A; Radia C; Harlow C; Monahan KJ
    Colorectal Dis; 2019 Jul; 21(7):760-766. PubMed ID: 30815953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population.
    West NP; Gallop N; Kaye D; Glover A; Young C; Hutchins GGA; Brockmoeller SF; Westwood AC; Rossington H; Quirke P;
    Histopathology; 2021 Nov; 79(5):690-699. PubMed ID: 33872400
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.